Kidiamix G (Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine)

Kidiamix G is an amino acid solution used in parenteral nutrition to support patients with impaired oral or enteral intake.

• Parenteral nutrition for patients unable to receive enteral nutrition: provides a complete profile of essential amino acids to meet protein requirements.
• Critical illness with increased catabolism: helps maintain nitrogen balance and supports tissue repair.
• Pre‑ and post‑operative care in major surgery: contributes to preservation of lean body mass and wound healing.

• Kidiamix G delivers a balanced mixture of essential amino acids directly into the bloodstream. These amino acids are taken up by cells and incorporated into nascent proteins, supporting protein synthesis, nitrogen balance, and various metabolic pathways. By bypassing the gastrointestinal tract, the solution ensures rapid availability of substrates needed for tissue repair, immune function, and metabolic homeostasis in patients receiving parenteral nutrition.

Kidiamix G may be associated with infusion‑related and metabolic reactions.

Common Side Effects

• Infusion site erythema or phlebitis: mild local irritation at the catheter site.
• Transient hypernatremia: slight increase in serum sodium during rapid infusion.
• Mild elevation of blood urea nitrogen: reflects increased nitrogen load.
• Temporary metabolic alkalosis: due to amino acid metabolism.

Serious or Rare Side Effects

• Anaphylactic reaction: severe hypersensitivity requiring immediate medical intervention.
• Severe hyperammonemia: excess ammonia accumulation, especially in hepatic impairment.
• Septicemia from contaminated solution: rare but life‑threatening infection.
• Significant electrolyte imbalance: may necessitate urgent correction.

Kidiamix G should be used with careful clinical monitoring.

• Assess renal function: monitor creatinine and urea levels before and during therapy.
• Monitor electrolytes: especially potassium, sodium, and calcium to avoid imbalances.
• Adjust in hepatic impairment: watch for ammonia accumulation and consider dose modification.
• Avoid in known hypersensitivity: discontinue if allergic reactions occur.
• Use aseptic technique: ensure sterility of infusion set and solution.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kidiamix G may interact with other therapies that affect nitrogen balance or electrolyte status.

Major Interactions (Avoid)

• Concurrent high‑dose nitrogen‑producing drugs (e.g., valproic acid): may exacerbate hyperammonemia.
• Co‑administration with other parenteral nutrition solutions containing overlapping amino acids: can lead to excess nitrogen load.

Moderate Interactions (Monitor Closely)

• Electrolyte‑containing IV fluids: monitor for combined electrolyte shifts.
• Renal replacement therapy: may require adjustment of amino acid infusion rate.
• Corticosteroids or other protein‑catabolic agents: monitor overall nitrogen balance.